Trial reportJournal of cosmetic dermatology2026
Efficacy and Safety of Transcutaneous Electrical Acupoint Stimulation for Improving Clinical Signs of Facial Skin Aging.
Trial report in Journal of cosmetic dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundSkin aging is a key focus in aesthetic and dermatologic medicine. Transcutaneous electrical acupoint stimulation (TEAS) is a noninvasive, acupuncture-based technique that integrates traditional meridian theory with modern electrical stimulation. This study evaluated the clinical efficacy and safety of TEAS in improving the clinical signs of facial skin aging and promoting facial rejuvenation.
objectiveThis study aimed to evaluate the effects of TEAS on the clinical signs of facial skin aging.
methodsNinety participants were randomly assigned to TEAS, acupuncture, or Sham-TEAS groups. The TEAS group received 30-min treatments, five times per week for four weeks. Primary and secondary outcomes were assessed using the VISIA analysis system and the FACE-Q scale.
resultsTEAS significantly reduced wrinkle scores at week 4 and week 8 compared with baseline (p < 0.001) and achieved greater improvement than acupuncture (p < 0.05). FACE-Q scores increased significantly in the TEAS and acupuncture groups compared with Sham-TEAS (p < 0.01), with greater improvement in Social Function in the TEAS group (p < 0.05). Both physician-rated and self-assessed GAIS and WSRS scores also improved in the TEAS group (p < 0.001).
conclusionTEAS appears to be a safe, noninvasive intervention that is primarily effective in reducing wrinkle severity and improving patient-reported outcomes, while showing limited effects on other VISIA parameters of facial skin aging.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.